Public Markets and M&A Panel08:30

Investment Panel

09:15

10:15 COFFEE BREAK

PANORAMA A PANORAMA C

Oncology I - Deal Making

10:30

Autoimmune & Inflammatory

10:30

08:20 WELCOME SPEECH

Ravi Sodha, Senior Director BD, Actelion PharmaceuticalsChandra Leo, Partner, HBM Partners ABStephanie Léouzon, Principal and Head, Torreya Partners (Europe) LLC Chaired by:

Featuring: Jim Phillips, Chief Executive Officer, Midatech Group Mick Cooper, Head of Research, Healthcare, Edison Group

Tim Haines, Partner, Abingworth LLP

Arthur Franken, Partner, Gilde Healthcare Bethan Hughes, Senior Business Analyst, Wellcome Trust Graziano Seghezzi, Partner, Sofinnova Partners Jeanne Bolger, VP Venture Investments, J&J Innovation Lionel Carnot, MD, Bay City Capital LLC Margarita Chavez, Director, Ventures & Early Stage Collaborations, AbbVie Markus Goebel, Partner, Novartis Venture Fund Olivier Litzka, Partner, Edmond de Rothschild Investment Partners

Chaired by:

Featuring:

BERNE

Oncology II - Investment

11:30

EUR OPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry8th

ANNUAL 03-04 MARCH 2015 | Hilton Zurich Airport Hotel | Switzerland

Rare & Orphan Diseases Panel

11:15

EMERGING TRACK PRESENTATIONS Jørgen Thorball, XOventure GmBH

08:00 REGISTRATION & COFFEE

10:30 Amphera B.V.

10:40 Athera Biotechnologies AB

10:50 TBA

11:00 Calypso Biotech SA

11:10 Cell Therapy Ltd.

11:20 Mendor

11:30 Oncos Therapeutics Ltd.

11:40 ISA Pharmaceuticals

Moderated by:

11:50 Otic Pharma

12:00 TBA

Anne Altmeyer, Vice President, BD, Head of Negotiations, Oncology, Novartis PharmaceuticalsFrans Wuite, President & Chief Executive Officer, Oncos TherapeuticsGuillaume Vignon, Director BD Oncology – Global BD and Licensing, EMD Serono Hamza Suria, President & CEO, AnaptysBio, Inc.Mike Khan, CMO, Silence Therapeutics PLCStephen Sands, Commercial Lead, Oncology/Immunology, F. Hoffmann La Roche AG

Kay Tait, Transaction Director in the Business Development Group, AstraZeneca

Francois Thomas, Managing Director, Thomas Conseil SPRL

Anja König, Managing Director, Novartis Venture FundBernhard Sixt, President & CEO, ImmunIDCarles Domenech, CEO, Ability PharmaceuticalsJakob Lindberg, CEO, Oncopeptides ABMichael Scherz, Founder and Chief Executive Officer, Metys Pharmaceuticals Peter Culpepper, CFO & COO, Provectus Biopharmaceuticals, Inc.Thilo Schroeder, Partner, Nextech Invest Ltd.

Gary Clements, Head of Research Alliances, Shire Pharmaceuticals Sten Verland, Partner, Sunstone Capital A/S

David Phillips, Partner, S.R.One, LimitedStjohn Mcgrath, Vice President BD, Bristol-Myers Squibb

Adrian Mills, CBO, Novimmune SAAndre Hoekema, SVP Corporate Development, Galapagos NV Dinesh Patel, President & CEO, Protagonist Therapeutics, Inc. Kia Motesharei, Head, Immunology Licensing, EMD Serono, Inc. Lothar Steidler, Vice President Technology, ActoGeniX NV Simon Kerry, CEO, Karus Therapeutics Ltd.

Chris Maggos, Consultant, BioConfidant SàrlRegina Hodits, General Partner, Wellington Partners

Chaired by:

Featuring:

Chaired by:

Featuring:

Co-Chaired by:

Featuring:

Co-Chaired by:

Featuring:

PANORAMA A+C

Neuroscience Panel

12:00

Platform Technologies & Novel Therapeutics Panel

Early Stage Investment Panel

NETWORKING LUNCH

12:10 Synthena AG

12:20 Histide AG

12:30 VTU Technology GmbH

12:40 Biophytis

12:50 Exploris Health AG

TRACK A PRESENTATIONS Tomas Kahn, Deutsche Bank

14:00 Silence Therapeutics PLC

Moderated by:

Alexander Breidenbach, Director, Global BD, F. Hoffmann La Roche AGGraham Birrell, Regional Head, Business Development, OCTJesse Schulman, CEO, Canbex Therapeutics LimitedKevin Cox, CEO, Imanova Ltd.Konrad Glund, CEO, Probiodrug AGPatrick Doyle, CEO, KineMed, Inc.Seth Lederman, CEO, Tonix Pharmaceuticals Holding Corp.

Charles Bailey, Head of Search & Evaluation, Neurosciences, Novartis Pharma AGChris Maggos, Consultant, BioConfidant Sàrl

Co-Chaired by:

Featuring:

Ajan Reginald, Chief Executive Officer, Cell Therapy Ltd.Heinz Schwer, CEO, Lanthio PharmaFabian Buller, Director, New Ventures, Covagen AG / J&J InnovationMalcolm Weir, Co-Founder, and CEO, Heptares TherapeuticsRao Movva, Executive Director, Novartis Institutes for BioMedical Research, Inc.

Esteban Pombo-Villar, COO, Oxford BioTherapeuticsKatya Smirnyagina, Partner, Capricorn Venture Partners NV

Co-Chaired by:

Featuring:

TRACK B PRESENTATIONS Mick Cooper, Edison GroupModerated by:

TRACK C PRESENTATIONS Hans Herklots, Capricon OneModerated by:

Carina Schmidt, Chief Executive Officer, Athera Biotechnologies ABFlorian Kemmerich, Chief Executive Officer, HistideHans Schambye, Chief Executive Officer, GALECTO BIOTECHFrank Kalkbrenner, Head Boehringer Ingelheim Venture Fund, Boehringer Ingelheim GmbH Jesús Martin-Garcia, General Partner, EclosionMichèle Ollier, Partner, Index VenturesNanna Lüneborg, Investment Director, Novo Seeds, Novo A/SSiro Perez, Venture Partner, Hadean Ventures

Jasper Bos, Director, MS VenturesChaired by:

Featuring:

NETWORKING RECEPTION

TRACK D PRESENTATIONS Hans Kuepper, Global Life Science

Oncopeptides AB

16:30 Metys Pharmaceuticals AG

16:45 Azanta A/S

17:00 OCT

17:15 Ability Pharmaceuticals

Moderated by:TRACK E PRESENTATIONS Fintan Walton, PharmaVentures Ltd.Moderated by:

13:00

12:15

16:15

16:15

14:15 Helsinn Healthcare SA

14:30 AnaptysBio, Inc.

14:45 Addex Therapeutics Ltd.

15:00 Midatech Pharma PLC

15:15 TBA

15:30 TBA

15:45 TBA

14:00 Lanthio Pharma

14:15 Heptares Therapeutics

14:30 ImmunID

14:45 NovImmune SA

15:00 Glide Technologies

15:15 Karus Therapeutics Ltd.

15:30 Mirna Therapeutics, Inc.

15:45 TBA

14:00 KineMed, Inc.

14:15 Probiodrug AG

14:30 Tonix Pharmaceuticals Holding Corp.

14:45 Kuros Biosurgery AG

15:00 Hansa Medical AB

15:15 Provectus Biopharmaceuticals, Inc.

15:30 TBA

15:45 TBA

PANORAMA A PANORAMA C BERNE

BerGenBio AS

16:30 Mission Therapeutics Ltd.

16:45 Protagonist Therapeutics, Inc.

17:00 Immunomic Therapeutics, Inc.

17:15

16:15

COFFEE BREAK16:00

17:3019:30

DanDrit Biotech

08:00 DAY 2 REGISTRATION & COFFEE

Partnering Panel I

08:30

Partnering Panel II

09:15

COFFEE BREAK10:00

Vaccines Panel

10:15

MedTech & Diagnostics Panel

11:00

END OF THE FORUM16:00

BLOOMBERG NEWS interview by Simeon BennettBoris Zaïtra, Head of Corporate M&A, F. Hoffmann-La Roche Ltd12:00

Jason Coloma, Global Head Venture & Innovation at Roche Partnering, F. Hoffmann La Roche AGPascal Touchon, Director - Scientific Cooperation & BD, Les Laboratoires ServierStjohn Mcgrath, Vice President Business Development, Bristol-Myers Squibb

Fintan Walton, CEO, PharmaVentures Ltd.

Corinne Savill, Head BD & Licensing, Novartis Pharma AGWilder Fulford, Principal, Torreya Partners (Europe) LLCChaired by:

Featuring:

Chaired by:

Featuring:

Jane Atkins, Global Licensing & BD, Takeda Pharmaceuticals International GmbH Stewart Kay, Director, Transactions, GlaxoSmithKline

Luca Bolliger, Vice President and Group Licensing Director, RECORDATI S.A.Fabien Sebille, Head of Alliances, Debiopharm International S.A.Vincent de Groot, Sr. Director, Ventures & Early Stage Collaborations, AbbVie

NETWORKING LUNCH12:30

AFTERNOON WORKSHOP13:30

Manfred Horst, Director, Licensing & External Research Europe, MSD France Philippe Lopes-Fernandes, SVP, Head of Global Licensing & BD, EMD Serono, Inc.

Beat Merz, MD, Rockport Venture Partners Eduardo Margallo, CEO, MedLumics S.L.Håkon Sæterøy, CEO, Pre Diagnostics ASJohn Kelly, Founder & CEO Atomo Diagnostics Neil Butler, CEO, SpectromicsThomas Taapken, CEO & CFO, Epigenomics AG

Arthur Franken, Partner, Gilde HealthcareRainer Metzger, VP Global BD Pharma, Qiagen

Ted Fjällman, CEO, Prokarium Ltd.William Hearl, President & CEO, Immunomic Therapeutics, Inc. Wouter Latour, CEO, Vaxart, Inc.

Chris Britten, Head, BD, Sanofi Pasteur MSDChaired by:

Featuring:

Co-Chaired by:

Featuring:

EMERGING TRACK PRESENTATIONS Jørgen Thorball, XOventure GmBH

09:15 Prokarium Ltd.

Moderated by:

09:25 Pre Diagnostics AS

09:35 MedLumics S.L.

EMERGING TRACK CONTINUED Jørgen Thorball, XOventure GmBHModerated by:

TRACK F PRESENTATIONS Hans Herklots, Capricorn OneModerated by:

Epigenomics AG

10:30 Cellular Biomedicine Group, Inc.

10:45 GamaMabs Pharma

11:00 BioCrypton, Inc.

11:15

10:15

Oryx GmbH & Co. KGOryx Translational Medicine

11:30 Vaxart, Inc.

10:15 Atomo Diagnostics

10:25 4D lifetec AG

10:35 Galecto Biotech

PANORAMA A PANORAMA C BERNE

"Licensing Agreements: What was written was what was really meant?"

PANORAMA A+C